nu skin enterprises - NUS

NUS

Close Chg Chg %
9.70 0.00 0.00%

Open Market

9.70

0.00 (0.00%)

Volume: 15.17K

Last Updated:

Dec 31, 2025, 10:34 AM EDT

Company Overview: nu skin enterprises - NUS

NUS Key Data

Open

$9.69

Day Range

9.62 - 9.74

52 Week Range

5.32 - 14.62

Market Cap

$474.34M

Shares Outstanding

48.75M

Public Float

47.56M

Beta

0.99

Rev. Per Employee

N/A

P/E Ratio

4.52

EPS

$2.21

Yield

243.90%

Dividend

$0.06

EX-DIVIDEND DATE

Nov 28, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

446.00K

 

NUS Performance

1 Week
 
-1.32%
 
1 Month
 
-1.82%
 
3 Months
 
-14.60%
 
1 Year
 
40.93%
 
5 Years
 
-82.23%
 

NUS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About nu skin enterprises - NUS

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

NUS At a Glance

Nu Skin Enterprises, Inc.
75 West Center Street
Provo, Utah 84601-4432
Phone 1-801-345-1000 Revenue 1.73B
Industry Household/Personal Care Net Income -146,594,000.00
Sector Consumer Non-Durables Employees 11,300
Fiscal Year-end 12 / 2025
View SEC Filings

NUS Valuation

P/E Current 4.522
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.198
Price to Book Ratio 0.527
Price to Cash Flow Ratio 3.06
Enterprise Value to EBITDA 5.162
Enterprise Value to Sales 0.359
Total Debt to Enterprise Value 0.768

NUS Efficiency

Revenue/Employee 153,281.77
Income Per Employee -12,972.92
Receivables Turnover 34.107
Total Asset Turnover 1.058

NUS Liquidity

Current Ratio 1.796
Quick Ratio 1.154
Cash Ratio 0.668

NUS Profitability

Gross Margin 68.233
Operating Margin 2.931
Pretax Margin -10.106
Net Margin -8.463
Return on Assets -8.951
Return on Equity -19.898
Return on Total Capital -12.977
Return on Invested Capital -11.908

NUS Capital Structure

Total Debt to Total Equity 73.409
Total Debt to Total Capital 42.333
Total Debt to Total Assets 32.556
Long-Term Debt to Equity 66.053
Long-Term Debt to Total Capital 38.091
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Nu Skin Enterprises - NUS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.70B 2.23B 1.97B 1.73B
Sales Growth
+4.41% -17.44% -11.53% -12.04%
Cost of Goods Sold (COGS) incl D&A
751.54M 703.42M 611.85M 550.23M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
125.02M 72.51M 69.60M 69.81M
Depreciation
111.60M 62.81M 57.70M 57.51M
Amortization of Intangibles
11.70M 9.70M 11.90M 12.30M
COGS Growth
+2.67% -6.40% -13.02% -10.07%
Gross Income
1.94B 1.52B 1.36B 1.18B
Gross Income Growth
+5.09% -21.70% -10.84% -12.93%
Gross Profit Margin
+72.12% +68.39% +68.93% +68.23%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.66B 1.36B 1.29B 1.13B
Research & Development
27.20M 23.30M 22.60M 13.00M
Other SG&A
1.63B 1.34B 1.27B 1.12B
SGA Growth
+4.14% -17.81% -5.41% -12.27%
Other Operating Expense
- - - -
-
Unusual Expense
52.03M 45.38M 19.79M 202.36M
EBIT after Unusual Expense
233.84M 113.96M 48.27M (151.59M)
Non Operating Income/Expense
9.62M (11.49M) (21.69M) 2.94M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 11.00M 13.50M 26.41M
Interest Expense Growth
- - -16.03% +22.73%
-
Gross Interest Expense
- 11.00M 13.50M 26.41M
Interest Capitalized
- - - -
-
Pretax Income
232.46M 88.97M 26.58M (175.05M)
Pretax Income Growth
-9.28% -61.73% -70.13% -758.63%
Pretax Margin
+8.62% +4.00% +1.35% -10.11%
Income Tax
85.19M (15.81M) 17.98M (28.46M)
Income Tax - Current - Domestic
1.46M 1.51M 3.90M 1.71M
Income Tax - Current - Foreign
77.39M 34.12M 29.18M 25.31M
Income Tax - Deferred - Domestic
3.67M (66.97M) (19.48M) (61.95M)
Income Tax - Deferred - Foreign
2.67M 15.53M 4.38M 6.47M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
147.27M 104.78M 8.60M (146.59M)
Minority Interest Expense
- - - -
-
Net Income
147.27M 104.78M 8.60M (146.59M)
Net Income Growth
-23.04% -28.85% -91.80% -1,805.57%
Net Margin Growth
+5.46% +4.71% +0.44% -8.46%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
147.27M 104.78M 8.60M (146.59M)
Preferred Dividends
- - - -
-
Net Income Available to Common
147.27M 104.78M 8.60M (146.59M)
EPS (Basic)
2.934 2.0955 0.1729 -2.9518
EPS (Basic) Growth
-19.82% -28.58% -91.75% -1,807.23%
Basic Shares Outstanding
50.19M 50.00M 49.71M 49.66M
EPS (Diluted)
2.8636 2.0738 0.1724 -2.9518
EPS (Diluted) Growth
-21.04% -27.58% -91.69% -1,812.18%
Diluted Shares Outstanding
51.43M 50.52M 49.86M 49.66M
EBITDA
410.89M 231.85M 137.66M 120.58M
EBITDA Growth
+8.78% -43.57% -40.63% -12.40%
EBITDA Margin
+15.24% +10.42% +6.99% +6.96%

Snapshot

Average Recommendation HOLD Average Target Price 7.50
Number of Ratings 1 Current Quarters Estimate 0.27
FY Report Date 03 / 2026 Current Year's Estimate 1.42
Last Quarter’s Earnings 0.30 Median PE on CY Estimate N/A
Year Ago Earnings 1.30 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 N/A
Mean Estimate 0.27 0.34 1.42 N/A
High Estimates 0.27 0.34 1.42 N/A
Low Estimate 0.27 0.34 1.42 N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Nu Skin Enterprises - NUS

Date Name Shares Transaction Value
Dec 12, 2025 Edwina D. Woodbury Director 42,979 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $10.35 per share 444,832.65
Mar 25, 2025 Justin Keisel EVP, President of Global Sales 90,776 Small acquisition under Rule 16a-6 Non-derivative transaction at $13.13 per share 1,191,888.88
Mar 25, 2025 Justin Keisel EVP, President of Global Sales 90,827 Small acquisition under Rule 16a-6 Non-derivative transaction at $6.99 per share 634,880.73
Mar 25, 2025 Justin Keisel EVP, President of Global Sales 90,874 Small acquisition under Rule 16a-6 Non-derivative transaction at $7.62 per share 692,459.88
Mar 25, 2025 Justin Keisel EVP, President of Global Sales 90,922 Small acquisition under Rule 16a-6 Non-derivative transaction at $7.44 per share 676,459.68
Feb 28, 2025 Ryan S. Napierski President and CEO; Director 643,433 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 James D. Thomas Chief Financial Officer 136,355 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Chayce D. Clark EVP and General Counsel 253,345 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 28, 2025 Steven K. Hatchett Chief Product Officer 155,565 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Nu Skin Enterprises in the News